antibody
A New Drug Could Reduce the Effects of Alzheimer's by 30 Percent
An 18-month study of an antibody called solanezumab suggests that the drug could help more people who suffer from the disease live a longer life.
Advertisement
An 18-month study of an antibody called solanezumab suggests that the drug could help more people who suffer from the disease live a longer life.